Seer (SEER) Cash from Investing Activities (2020 - 2026)
Seer (SEER) posted quarterly Cash from Investing Activities of $18.1 million for Q1 2026, down 26.55% year-over-year from $24.6 million in Q1 2025, and up 39.3% quarter-over-quarter from $13.0 million in Q4 2025.
Seer (SEER) Cash from Investing Activities (2020 - 2026) Analysis & Trends
Seer's Cash from Investing Activities history runs 7 years deep, the most recent figure standing at $18.1 million for Q1 2026.
- In Q1 2026, Cash from Investing Activities fell 26.55% year-over-year to $18.1 million; the TTM figure through Mar 2026 stood at $55.0 million (down 5.34% YoY), while the FY2025 annual figure was $61.5 million, down 6.54% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at $18.1 million, up from $13.0 million in the prior quarter.
- The five-year high for Cash from Investing Activities was $32.4 million in Q1 2024, with the low at -$133.2 million in Q2 2022.
- The 5-year median for Cash from Investing Activities is $13.0 million (2025), against an average of $3.6 million.
- The sharpest annual moves came in 2023 and 2024: Cash from Investing Activities slumped 350.0% in 2023, then soared 570.03% in 2024.
- Seer's Cash from Investing Activities stood at -$2.7 million in 2022, then soared by 325.41% to $6.1 million in 2023, then jumped by 159.3% to $15.8 million in 2024, then slipped by 18.11% to $13.0 million in 2025, then soared by 39.3% to $18.1 million in 2026.
- Business Quant data shows SEER's Cash from Investing Activities at $18.1 million in Q1 2026, $13.0 million in Q4 2025, and $16.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -45.80 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -92.70 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -1.66 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -49.35 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 19.77 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -229.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -363.46 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 24.51 Mn |
| 10 | Seer | 230.63 Mn | 230.63 Mn | 1.51 Mn | -11.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -11.47 Mn |
| Jun 30, 2026 | -11.47 Mn |
| Mar 31, 2026 | 18.08 Mn |
| Mar 31, 2026 | 18.08 Mn |
| Dec 31, 2025 | 12.98 Mn |
| Dec 31, 2025 | 12.98 Mn |
| Sep 30, 2025 | 16.60 Mn |
| Sep 30, 2025 | 16.60 Mn |
| Jun 30, 2025 | 7.36 Mn |
| Jun 30, 2025 | 7.36 Mn |
| Mar 31, 2025 | 24.61 Mn |
| Mar 31, 2025 | 24.61 Mn |
| Dec 31, 2024 | 15.85 Mn |
| Dec 31, 2024 | 15.85 Mn |
| Sep 30, 2024 | 26.44 Mn |
| Sep 30, 2024 | 26.44 Mn |
| Jun 30, 2024 | -8.78 Mn |
| Jun 30, 2024 | -8.78 Mn |
| Mar 31, 2024 | 32.36 Mn |
| Mar 31, 2024 | 32.36 Mn |